Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.68 USD | +0.66% | -2.64% | +7.73% |
May. 02 | UBS Adjusts Price Target on Scotts Miracle-Gro to $74 From $79, Maintains Neutral Rating | MT |
May. 02 | Truist Adjusts Scotts Miracle-Gro's PT to $65 From $75, Keeps Hold Rating | MT |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- One of the major weak points of the company is its financial situation.
- The firm trades with high earnings multiples: 27.98 times its 2024 earnings per share.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.73% | 3.9B | B- | ||
+19.95% | 40.06B | C | ||
-.--% | 11.1B | - | B+ | |
+7.11% | 8.43B | A | ||
+1.35% | 6.46B | B- | ||
-2.09% | 6.16B | B+ | ||
-5.87% | 5.61B | B | ||
+37.82% | 5.46B | B- | ||
-18.11% | 5.11B | - | C- | |
-14.56% | 4.51B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SMG Stock
- Ratings The Scotts Miracle-Gro Company